UTHEVER® NMN: The Only NMN to Receive EFSA Positive Safety Opinion for Novel Food
July 2026
Access the UTHEVER® NMN white paper to discover this anti-ageing ingredient’s technical advantages & official compliance documents, including FDA NDI clearance in the U.S. and a positive EFSA safety opinion in Europe – the first-ever EU official safety endorsement for NMN. Learn the recommended safe daily intake of NMN as assessed by regulatory authorities in the white paper. Next, UTHEVER® NMN will be added to the EU Novel Food list, helping brands accelerate early market entry with strong regulatory support.
This Technical Paper is brought to you by EffePharm Ltd.
Brain & Mental Health
OmniActive’s root-only ashwagandha secures USP verification
OmniActive Health Technologies’ Zenroot has been approved by the US Pharmacopeia (USP) and is part of its Ingredient Verification Program for Dietary Ingredients, making it the first root-only ashwagandha to achieve this.
Brain & Mental Health
Glucose spotted as key driver of human brain evolution in study
Scientists have found evidence that fruit, honey, and other naturally sweet foods have helped fuel the evolution of the human brain, challenging the popular scientific standpoint of meat consumption being the main driver of human...
Brain & Mental Health
Psilocybin therapy eases PTSD symptoms in US veteran pilot trial
A pilot trial with 12 US veterans with post-traumatic stress disorder (PTSD) showed that psilocybin — the active ingredient in magic mushrooms — eased the symptoms for 75% of the participants after one month. Their...
